Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
WuXi ATU and Wugen Announce Manufacturing Partnership to Expedite the Delivery of Novel Cell Cancer Immunotherapies 2022-06-16 08:00
Novotech and Medidata expand partnership to continue advancements in clinical research 2022-06-16 08:00
SOPHiA GENETICS Publishes Results of 2022 Annual General Meeting 2022-06-16 00:15
I-Mab Partner MorphoSys Announces New License Agreements for Felzartamab and TJ210 2022-06-15 22:37
AnchorDx's Non-invasive Lung Cancer Early Diagnosis Product, PulmoSeek, Completes EU CE Marking Requirements 2022-06-15 21:00
Burning Rock Presents Latest Clinical Data from THUNDER Study at 2022 ASCO Annual Meeting 2022-06-15 20:01
Clinical Study Collaborator HCL Sends First Surgically Excised Ovarian Cancer Tumors to BioVaxys for BVX-0918 Vaccine Process Development 2022-06-15 20:00
Pierre Fabre and Lonza Enter Manufacturing Agreement for W0180 Antibody Drug Product 2022-06-15 14:30
Gracell Biotechnologies to Participate in Three Upcoming Investor Conferences 2022-06-14 20:00
Zhimeng Biopharma will report positive phase 1b trial results on its HBV capsid inhibitor ZM-H1505R in the upcoming International Liver Congress 2022-06-14 20:00
PROXIMIE RAISES $80 MILLION IN SERIES C FUNDING TO ACCELERATE PRODUCT EXPANSION OF FULL-SERVICE CONNECTED SURGICAL PLATFORM 2022-06-14 19:00
Cellenkos Receives FDA Clearance of Investigational New Drug (IND) Application for CK0804 as Add on Therapy to Ruxolitinib for the Treatment of Myelofibrosis 2022-06-14 17:00
Kintor Pharma and Etana's Collaboration on Pruxelutamide's COVID-19 Project Awarded with Belt and Road Innovation Project and Fund Support from the Science and Technology Department of Jiangsu Province 2022-06-14 12:35
BIO Asia-Taiwan 2022 kicks off July 27 with theme 'Connecting the Asian Value Chain' 2022-06-14 09:00
Innovent and Etana Jointly Announce the Approval of Bevagen® (Bevacizumab Biosimilar) by the Indonesian Food and Drugs Authority (BPOM) 2022-06-14 08:00
Treadwell Announces Initiation of Patient Dosing in TWT-203, a Phase 1b/2 study of TTK Inhibitor, CFI-402257, in Patients with ER+/Her2- Breast cancer 2022-06-14 04:01
Good News from Taiwan Participants in BIO 2022 - Pharmasaga and PrecisemAb Make It to the Start-Up Stadium Finalists Defeating Hundred Teams 2022-06-14 00:00
Dompé Announces Results of Phase 2 Study Evaluating the Efficacy and Safety of Reparixin in Patients with Severe COVID-19 Pneumonia 2022-06-13 21:20
Novavax COVID-19 Vaccine Nuvaxovid™ Provisionally Registered in Australia as a Booster in Individuals Aged 18 and Over 2022-06-13 19:00
POSITIVE DATA FOR PAXALISIB IN TWO CHILDHOOD BRAIN CANCERS PRESENTED AT 20TH ISPNO ANNUAL MEETING 2022-06-13 19:00
1 130 131 132 133 134 413